Price points for MR systems will vary not only by the solution selected, but also by the configuration, based on the customer’s current and future needs. Similar to other radiological imaging technologies such as Computed Tomography (CT), Molecular Imaging, and Cath Lab and Vascular, customers have the ability to select various hardware and software options for MR systems. Siemens has quoted their MAGNETOM Sola 1.5T MR system a net price between $1.28 million to $1.77 million and on average a net price of $1.54 million. While their MAGNETOM Altea 1.5T MR system has been quoted between $850k to $1.31 million with an average quoted net price of $1.11 million. GE has quoted their Signa Voyager 1.5T MRI system a net price between $1.11 million to $1.81 million and on average a net price of $1.53 million, while their Signa Artist 1.5T MR system has been quoted at between $1.38 million and $1.78 million with an average quoted net price of $1.56 million. Philips has quoted their Ingenia Ambition $1.5T MRI system a net price between $1.05 million to $1.35 million, and on average a net price of $1.13 million.

As one would expect, there are clinical benefits when purchasing a 3.0T MR system. However, these systems typically do have a higher cost when compared to the 1.5T MR systems. The following is net pricing data of the top 5 MR solutions symplr has seen in the last 12 months. Siemens has quoted their MAGNETOM Vida 3.0T MR system a net price between $1.67 million into $2.28 million, and on average a net price of $2.06 million. They have also quoted their MAGNETOM Lumina 3.0T MRI system a net price between $1.42 million to $1.76 million, and on average a net price of $1.61 million. Canon has quoted their Vantage Galan 3.0T MR system a net price between $1.66 million to $1.93 million, and on average a net price of $1.83 million. GE has quoted their Signa Hero 3.0T MR and their Signa Premier XT systems between $1.63 million to $2.12 million, with an average quoted net price of $1.87 million; and $1.65 million to $2.02 million with an average quoted net price of $1.72 million, respectively.


As briefly mentioned, selecting a solution will vary by facility and will be driven by current and future needs. However, to ensure a healthcare organization is making an informed decision and a 12-to-15-year capital investment that’s in line with the department’s utilization, symplr has identified the advantage of establishing a Value Analysis Committee (VAC). The committee alleviates the burden of asking a specific group to make a selection based on relationships or experiences with an OEM. The VAC would assist in gathering clinical data, recall data, educational data, and financial data. The information would then be utilized to make transparent and informed decisions to improve the healthcare organization’s patient outcomes.

About the author: Edward Rodriguez, MBA, R.T. (R) (MR), is a clinical expert with symplr who specializes in MR, SPECT, and molecular imaging.

Back to HCB News

MRI Homepage